What best means in this list
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Immunotherapy classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
Ratings and dated fundamentals
| 1 | Halozyme Therapeutics, Inc. | HALO | 4 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $109.84 | $12,466,620,320 | 30.14 | 86.85 |
| 2 | Krystal Biotech, Inc. Common Stock | KRYS | 4 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $327.3 | $9,687,699,022.8 | 40.12 | 7.13 |
| 3 | Regeneron Pharmaceuticals Inc | REGN | 4 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $739.57 | $76,142,420,475.16 | 17.59 | 2.4 |
| 4 | United Therapeutics Corp | UTHR | 4 | 2025-10-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $532.78 | $22,851,302,883.76 | 17.43 | 3.57 |
| 5 | Ligand Pharmaceuticals Inc. | LGND | 3.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $295 | $5,881,004,655 | 29.82 | 6.08 |
| 6 | Merck & Co., Inc. | MRK | 3.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $142.38 | $351,275,897,818.44 | 110.71 | Not reported |
| 7 | Amgen Inc | AMGN | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $407.44 | $220,275,104,117.2 | 25.19 | Not reported |
| 8 | Pfizer Inc. | PFE | 3 | 2025-11-04 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $27.82 | $158,564,919,245.98 | 36.59 | 1.85 |
| 9 | Tango Therapeutics, Inc. | TNGX | 3 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $22.57 | $3,805,535,983.19 | Not reported | 3.71 |
| 10 | Adaptive Biotechnologies Corporation Common Stock | ADPT | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $26.09 | $4,163,855,517.78 | Not reported | 27.64 |
| 11 | Beam Therapeutics Inc. Common Stock | BEAM | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.6 | $2,540,876,559 | Not reported | 2.38 |
| 12 | Biogen Inc. Common Stock | BIIB | 2.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $218.43 | $32,248,375,466.31 | 38.64 | 1.71 |
| 13 | CytomX Therapeutics, Inc. | CTMX | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.47 | $538,211,231.48 | Not reported | 1.78 |
| 14 | Immunovant, Inc. Common Stock | IMVT | 2.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $30.26 | $6,250,284,157.32 | Not reported | 8.5 |
| 15 | Incyte Genomics Inc | INCY | 2.5 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $112.75 | $22,660,234,209.25 | 14.05 | 3.57 |
| 16 | Iovance Biotherapeutics, Inc. Common Stock | IOVA | 2.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.31 | $6,029,049,759.92 | Not reported | 8.19 |
| 17 | Nurix Therapeutics, Inc. Common stock | NRIX | 2.5 | 2025-10-09 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.21 | $2,304,991,179.43 | Not reported | 5.72 |
| 18 | Arcus Biosciences, Inc. | RCUS | 2.5 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $23.83 | $3,034,354,350.08 | Not reported | Not reported |
| 19 | Sanofi American Depositary Shares (Each representing one-half of one ordinary share) | SNY | 2.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.23 | $98,115,104,144.16 | 11.06 | Not reported |
| 20 | TG Therapeutics, Inc. | TGTX | 2.5 | 2025-11-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $53.34 | $8,164,703,287.02 | 18.49 | 13.52 |
| 21 | Zymeworks Inc. | ZYME | 2.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $25.26 | $1,792,430,427.66 | Not reported | 22.3 |
| 22 | Acumen Pharmaceuticals, Inc. Common Stock | ABOS | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.1 | $151,866,298.5 | Not reported | 2.65 |
| 23 | Arbutus Biopharma Corporation Common Stock | ABUS | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.18 | $827,003,950.3 | 5.4 | 3.2 |
| 24 | Aclaris Therapeutics, Inc. | ACRS | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.79 | $557,883,804.47 | Not reported | 4.48 |
| 25 | ALX Oncology Holdings Inc. Common Stock | ALXO | 2 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.18 | $163,166,856.46 | Not reported | 1.2 |
| 26 | AnaptysBio, Inc. Common Stock | ANAB | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $46.21 | $1,381,459,225.24 | Not reported | Not reported |
| 27 | Atara Biotherapeutics, Inc | ATRA | 2 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.23 | $92,648,063.3 | Not reported | Not reported |
| 28 | Bristol-Myers Squibb Co. | BMY | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $59.58 | $121,704,939,204.48 | 13.11 | 5.45 |
| 29 | Cabaletta Bio, Inc. Common Stock | CABA | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.95 | $330,613,617.75 | Not reported | 1.57 |
| 30 | Cullinan Therapeutics, Inc. Common Stock | CGEM | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.46 | $994,923,569.24 | Not reported | 3.09 |
| 31 | Compass Therapeutics, Inc. Common Stock | CMPX | 2 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.98 | $177,098,455.61 | Not reported | 1.07 |
| 32 | Corvus Pharmaceuticals, Inc. | CRVS | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.21 | $858,874,838.24 | Not reported | 3.81 |
| 33 | Genelux Corporation Common Stock | GNLX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.5 | $113,113,337.5 | Not reported | 7.02 |
| 34 | HUTCHMED (China) Limited American Depositary Shares | HCM | 2 | 2025-11-28 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $13.67 | $2,384,943,713.08 | 5.22 | 1.91 |
| 35 | Janux Therapeutics, Inc. Common Stock | JANX | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $18.5 | $1,131,030,300.5 | Not reported | 1.22 |
| 36 | Kyverna Therapeutics, Inc. Common Stock | KYTX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.18 | $382,192,483.92 | Not reported | 2.31 |
| 37 | MacroGenics, Inc. | MGNX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $3.55 | $226,135,663.85 | Not reported | 5.27 |
| 38 | Metagenomi Therapeutics, Inc. Common Stock | MGX | 2 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.99 | $37,520,220.69 | Not reported | 0.33 |
| 39 | Moderna, Inc. Common Stock | MRNA | 2 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $197 | $78,649,470,133 | Not reported | 11.63 |
| 40 | Nkarta, Inc. Common Stock | NKTX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.22 | $159,007,036.02 | Not reported | 0.64 |
| 41 | Replimune Group, Inc. | REPL | 2 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $13.04 | $1,228,624,027.36 | Not reported | 11.63 |
| 42 | Scholar Rock Holding Corporation Common Stock | SRRK | 2 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $42.2 | $5,139,338,900.4 | Not reported | 20.25 |
| 43 | TScan Therapeutics, Inc. Common Stock | TCRX | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.23 | $15,467,225.99 | Not reported | 0.22 |
| 44 | Xencor, Inc. | XNCR | 2 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $24.5 | $1,821,658,226.5 | Not reported | 3.62 |
| 45 | Adicet Bio, Inc. Common Stock | ACET | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $5.74 | $53,734,952.6 | Not reported | 0.45 |
| 46 | Allogene Therapeutics, Inc. Common Stock | ALLO | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.4 | $483,687,233.4 | Not reported | 1.11 |
| 47 | Actinium Pharmaceuticals, Inc | ATNM | 1.5 | 2025-11-24 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.08 | $33,956,750.88 | 3 | 1.12 |
| 48 | Bicara Therapeutics Inc. Common Stock | BCAX | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.26 | $1,142,144,840.84 | Not reported | 2.44 |
| 49 | BeyondSpring Inc. Ordinary Shares | BYSI | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.61 | $25,041,970.38 | Not reported | Not reported |
| 50 | Candel Therapeutics, Inc. Common Stock | CADL | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.66 | $739,169,337.9 | Not reported | 5.86 |
| 51 | Compugen Ltd | CGEN | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.12 | $200,823,203.12 | 5.68 | 1.95 |
| 52 | Coherus Oncology, Inc. Common Stock | CHRS | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.07 | $165,316,033.62 | Not reported | 2.72 |
| 53 | Calidi Biotherapeutics, Inc. | CLDI | 1.5 | 2025-08-08 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.04 | $2,687,551.36 | Not reported | 0.86 |
| 54 | Coya Therapeutics, Inc. Common Stock | COYA | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.99 | $117,054,666.51 | Not reported | 2.7 |
| 55 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 1.5 | 2025-08-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $5.27 | $101,928,614.11 | Not reported | 1 |
| 56 | Curis Inc | CRIS | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.71 | $1,482,700.62 | Not reported | 0.32 |
| 57 | CRISPR Therapeutics AG | CRSP | 1.5 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $50.44 | $4,877,177,417.32 | Not reported | 2.79 |
| 58 | Cue Biopharma, Inc. | CUE | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $22.33 | $162,214,364.62 | Not reported | 70.22 |
| 59 | Editas Medicine, Inc. Common Stock | EDIT | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.84 | $436,167,299.4 | Not reported | 4.14 |
| 60 | Fortress Biotech, Inc. | FBIO | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.09 | $69,620,015.08 | 0.62 | 0.34 |
| 61 | Greenwich LifeSciences, Inc. | GLSI | 1.5 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.14 | $222,228,069.12 | Not reported | 71.3 |
| 62 | GeoVax Labs, Inc. New | GOVX | 1.5 | 2025-07-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.29 | $2,112,025.04 | Not reported | 1.2 |
| 63 | Werewolf Therapeutics, Inc. Common Stock | HOWL | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.91 | $44,225,150.06 | Not reported | 2.71 |
| 64 | ImmunityBio, Inc. Common Stock | IBRX | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.91 | $10,502,977,465.43 | Not reported | Not reported |
| 65 | Immix Biopharma, Inc. Common Stock | IMMX | 1.5 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $9.29 | $664,600,227.06 | Not reported | 2.9 |
| 66 | Immunic, Inc. Common Stock | IMUX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.56 | $103,152,170.52 | Not reported | 0.81 |
| 67 | IN8bio, Inc. Common Stock | INAB | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.38 | $13,604,568.54 | Not reported | 0.74 |
| 68 | Inhibrx Biosciences, Inc. Common Stock | INBX | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $92.76 | $1,365,210,141.6 | Not reported | Not reported |
| 69 | Century Therapeutics, Inc. Common Stock | IPSC | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.46 | $264,369,968.66 | Not reported | 1.14 |
| 70 | Moleculin Biotech, Inc. | MBRX | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.42 | $3,010,400 | Not reported | 0.26 |
| 71 | MeiraGTx Holdings plc Ordinary Shares | MGTX | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $10.5 | $1,008,451,458 | 12.77 | 4.67 |
| 72 | Monopar Therapeutics Inc. Common Stock | MNPR | 1.5 | 2025-08-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $83.98 | $563,688,204.56 | Not reported | 4.31 |
| 73 | Marker Therapeutics, Inc. Common Stock | MRKR | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.95 | $15,839,470.65 | Not reported | 1.3 |
| 74 | Nektar Therapeutics | NKTR | 1.5 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $40.8 | $1,393,034,155.2 | Not reported | 1.54 |
| 75 | Intellia Therapeutics, Inc | NTLA | 1.5 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $12.6 | $1,765,596,331.8 | Not reported | 2.43 |
| 76 | Opko Health Inc. | OPK | 1.5 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.37 | $1,022,469,668.25 | Not reported | 0.86 |
| 77 | Oruka Therapeutics, Inc. Common Stock | ORKA | 1.5 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $77.28 | $5,116,685,538.72 | Not reported | 4.59 |
| 78 | Phio Pharmaceuticals Corp. Common Stock | PHIO | 1.5 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.97 | $11,304,745.98 | Not reported | 0.9 |
| 79 | Pyxis Oncology, Inc. Common Stock | PYXS | 1.5 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.99 | $165,982,019.5 | Not reported | 14.51 |
| 80 | SELLAS Life Sciences Group, Inc. Common Stock | SLS | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $11.26 | $2,273,908,683.34 | Not reported | 16.52 |
| 81 | Vir Biotechnology, Inc. Common Stock | VIR | 1.5 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11.12 | $1,881,681,452.96 | Not reported | 1.92 |
| 82 | Xenetic Biosciences, Inc. | XBIO | 1.5 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.12 | $4,967,543.72 | Not reported | 0.82 |
| 83 | Zenas BioPharma, Inc. Common Stock | ZBIO | 1.5 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $26.24 | $1,710,237,211.52 | Not reported | 6.92 |
| 84 | Zura Bio Limited Class A Ordinary Shares | ZURA | 1.5 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $4.13 | $395,774,335.81 | Not reported | 2.01 |
| 85 | AETHLON MEDICAL INC | AEMD | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.01 | $4,273,927.36 | Not reported | Not reported |
| 86 | Agenus Inc. | AGEN | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $7.54 | $339,453,868.78 | 3.69 | Not reported |
| 87 | Ainos, Inc. Common Stock | AIMD | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.21 | $8,934,728.33 | Not reported | 2.72 |
| 88 | Alzamend Neuro, Inc. Common Stock | ALZN | 1 | 2025-09-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.34 | $6,466,468.82 | Not reported | 1.11 |
| 89 | Anixa Biosciences, Inc. | ANIX | 1 | 2025-09-25 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.91 | $101,162,663.82 | Not reported | 7.66 |
| 90 | Artiva Biotherapeutics, Inc. Common Stock | ARTV | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $6.8 | $332,452,822.8 | Not reported | 0.96 |
| 91 | Atossa Therapeutics, Inc. Common Stock | ATOS | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.42 | $24,149,901.16 | Not reported | 0.9 |
| 92 | Perspective Therapeutics, Inc. | CATX | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.71 | $309,351,006.73 | Not reported | 0.96 |
| 93 | Celularity Inc. Class A Common Stock | CELU | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.46 | $42,261,103.06 | Not reported | Not reported |
| 94 | Creative Medical Technology Holdings, Inc. Common Stock | CELZ | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.86 | $5,672,236.04 | Not reported | 0.65 |
| 95 | Context Therapeutics Inc. Common Stock | CNTX | 1 | 2025-11-05 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.3 | $27,471,873.92 | Not reported | 0.72 |
| 96 | Caribou Biosciences, Inc. Common Stock | CRBU | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.48 | $51,588,255.26 | Not reported | 0.53 |
| 97 | Cel-Sci Corporation | CVM | 1 | 2025-12-23 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.95 | $34,298,524.65 | Not reported | 3.13 |
| 98 | Edesa Biotech, Inc. Common Shares | EDSA | 1 | 2025-12-31 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.66 | $35,286,173.46 | Not reported | Not reported |
| 99 | Elicio Therapeutics, Inc. Common Stock | ELTX | 1 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.81 | $47,570,206.42 | Not reported | 5.99 |
| 100 | Enlivex Ltd. Ordinary Shares | ENLV | 1 | 2025-12-01 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.28 | $5,514,679.71 | 0 | 0 |
| 101 | Equillium, Inc. Common Stock | EQ | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.44 | $91,307,638.08 | Not reported | 1.63 |
| 102 | Estrella Immunopharma, Inc. Common Stock | ESLA | 1 | 2025-11-12 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.42 | $18,160,358.22 | Not reported | Not reported |
| 103 | Fate Therapeutics, Inc. | FATE | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.13 | $255,217,694.82 | Not reported | Not reported |
| 104 | Genprex, Inc. Common Stock | GNPX | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.75 | $2,254,199.75 | Not reported | 0.15 |
| 105 | GRI Bio, Inc. Common Stock | GRI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.68 | $3,672,673.2 | Not reported | 0.36 |
| 106 | HCW Biologics Inc. Common Stock | HCWB | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.53 | $2,809,575.72 | Not reported | 0.38 |
| 107 | TuHURA Biosciences, Inc. Common Stock | HURA | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.93 | $122,992,370.81 | Not reported | 6.65 |
| 108 | iBio, Inc. Common Stock | IBIO | 1 | 2025-09-05 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.92 | $59,162,675.52 | Not reported | 0.69 |
| 109 | Insight Molecular Diagnostics Inc. Common Stock | IMDX | 1 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.28 | $107,335,651.52 | Not reported | Not reported |
| 110 | Imunon, Inc. Common Stock | IMNN | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.07 | $6,004,201.21 | Not reported | 1.43 |
| 111 | Indaptus Therapeutics, Inc. Common Stock | INDP | 1 | 2025-08-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.37 | $268,384,307.88 | Not reported | 23.6 |
| 112 | MiNK Therapeutics, Inc. Common Stock | INKT | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $11 | $56,133,022 | Not reported | Not reported |
| 113 | INmune Bio Inc. Common stock | INMB | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.83 | $50,789,433.87 | Not reported | 2.49 |
| 114 | Inovio Pharmaceuticals, Inc. | INO | 1 | 2025-11-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.09 | $112,703,294.62 | Not reported | 25.78 |
| 115 | INVO Fertility, Inc. Common Stock | IVF | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.74 | $1,855,407.76 | Not reported | 0.11 |
| 116 | Kairos Pharma, Ltd. | KAPA | 1 | 2025-12-03 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $0.96 | $3,248,274.99 | Not reported | Not reported |
| 117 | Liminatus Pharma, Inc. Class A Common Stock | LIMN | 1 | 2025-10-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.69 | $4,956,433.83 | Not reported | 16.49 |
| 118 | Lunai Bioworks Inc. Common Stock | LNAI | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.12 | $5,077,956.8 | Not reported | Not reported |
| 119 | MAIA Biotechnology, Inc. | MAIA | 1 | 2025-11-27 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $1.15 | $69,949,720.6 | Not reported | 3.38 |
| 120 | Neuphoria Therapeutics Inc. Common Stock | NEUP | 1 | 2025-09-29 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $3.35 | $100,710.94 | Not reported | 0 |
| 121 | NextCure, Inc. Common Stock | NXTC | 1 | 2025-10-30 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $6.78 | $31,034,494.02 | Not reported | 2.55 |
| 122 | Omeros Corporation | OMER | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $19.12 | $1,384,064,601.92 | 11.09 | Not reported |
| 123 | OS Therapies Incorporated | OSTX | 1 | 2025-11-17 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.62 | $74,723,836.5 | Not reported | Not reported |
| 124 | PDS Biotechnology Corporation Common Stock | PDSB | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $1.02 | $57,090,764.76 | Not reported | Not reported |
| 125 | Precigen, Inc. Common Stock | PGEN | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.6 | $2,721,067,877.2 | Not reported | 62.44 |
| 126 | Q32 Bio Inc. Common Stock | QTTB | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $8.09 | $240,834,979.94 | 7.13 | 2.27 |
| 127 | Revelation Biosciences, Inc. Common Stock | REVB | 1 | 2025-11-10 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.77 | $3,082,765.64 | Not reported | 0.31 |
| 128 | SAB Biotherapeutics, Inc. Common Stock | SABS | 1 | 2025-11-18 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $2.89 | $262,950,603.52 | Not reported | 1.22 |
| 129 | Summit Therapeutics Inc. Common Stock | SMMT | 1 | 2025-10-28 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $17.17 | $13,697,360,666.34 | Not reported | 21.74 |
| 130 | Senti Biosciences Holdings, Inc. Common Stock | SNTI | 1 | 2025-08-07 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.32 | $10,019,267.36 | Not reported | Not reported |
| 131 | Sutro Biopharma, Inc. | STRO | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $15.32 | $254,023,539.72 | Not reported | Not reported |
| 132 | Alaunos Therapeutics, Inc. Common Stock | TCRT | 1 | 2025-08-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.78 | $1,984,114.88 | Not reported | 3.04 |
| 133 | TriSalus Life Sciences, Inc. Common Stock | TLSI | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $4.13 | $254,303,098 | Not reported | 38.82 |
| 134 | Theriva Biologics, Inc. | TOVX | 1 | 2025-08-11 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $0.23 | $10,422,224.9 | Not reported | 0.86 |
| 135 | Tevogen Inc. Common Stock | TVGN | 1 | 2025-11-14 | 2025 FY | google/gemini-2.5-flash | 2026-10-08 | $7.06 | $45,971,472.4 | Not reported | Not reported |
| 136 | Vor Biopharma Inc. Common Stock | VOR | 1 | 2025-11-07 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $19.13 | $1,131,774,684.22 | 1.8 | Not reported |
| 137 | XBiotech Inc | XBIT | 1 | 2025-11-06 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $2.2 | $67,073,008.2 | Not reported | 0.52 |
| 138 | Xilio Therapeutics, Inc. Common Stock | XLO | 1 | 2025-11-13 | 2025 FY | google/gemini-2.5-flash-lite | 2026-10-08 | $9.01 | $59,287,142.49 | Not reported | 0.82 |
No matching rows. Clear the filter to see all records.
138 companies with eligible ratings and dated fundamentals, from 188 eligible companies in this selection.
Halozyme Therapeutics, Inc. (HALO) ↗Krystal Biotech, Inc. Common Stock (KRYS) ↗Regeneron Pharmaceuticals Inc (REGN) ↗United Therapeutics Corp (UTHR) ↗Ligand Pharmaceuticals Inc. (LGND) ↗Merck & Co., Inc. (MRK) ↗Amgen Inc (AMGN) ↗Pfizer Inc. (PFE) ↗Tango Therapeutics, Inc. (TNGX) ↗Adaptive Biotechnologies Corporation Common Stock (ADPT) ↗Beam Therapeutics Inc. Common Stock (BEAM) ↗Biogen Inc. Common Stock (BIIB) ↗CytomX Therapeutics, Inc. (CTMX) ↗Immunovant, Inc. Common Stock (IMVT) ↗Incyte Genomics Inc (INCY) ↗Iovance Biotherapeutics, Inc. Common Stock (IOVA) ↗Nurix Therapeutics, Inc. Common stock (NRIX) ↗Arcus Biosciences, Inc. (RCUS) ↗Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) ↗TG Therapeutics, Inc. (TGTX) ↗Zymeworks Inc. (ZYME) ↗Acumen Pharmaceuticals, Inc. Common Stock (ABOS) ↗Arbutus Biopharma Corporation Common Stock (ABUS) ↗Aclaris Therapeutics, Inc. (ACRS) ↗ALX Oncology Holdings Inc. Common Stock (ALXO) ↗AnaptysBio, Inc. Common Stock (ANAB) ↗Atara Biotherapeutics, Inc (ATRA) ↗Bristol-Myers Squibb Co. (BMY) ↗Cabaletta Bio, Inc. Common Stock (CABA) ↗Cullinan Therapeutics, Inc. Common Stock (CGEM) ↗Compass Therapeutics, Inc. Common Stock (CMPX) ↗Corvus Pharmaceuticals, Inc. (CRVS) ↗Genelux Corporation Common Stock (GNLX) ↗HUTCHMED (China) Limited American Depositary Shares (HCM) ↗Janux Therapeutics, Inc. Common Stock (JANX) ↗Kyverna Therapeutics, Inc. Common Stock (KYTX) ↗MacroGenics, Inc. (MGNX) ↗Metagenomi Therapeutics, Inc. Common Stock (MGX) ↗Moderna, Inc. Common Stock (MRNA) ↗Nkarta, Inc. Common Stock (NKTX) ↗Replimune Group, Inc. (REPL) ↗Scholar Rock Holding Corporation Common Stock (SRRK) ↗TScan Therapeutics, Inc. Common Stock (TCRX) ↗Xencor, Inc. (XNCR) ↗Adicet Bio, Inc. Common Stock (ACET) ↗Allogene Therapeutics, Inc. Common Stock (ALLO) ↗Actinium Pharmaceuticals, Inc (ATNM) ↗Bicara Therapeutics Inc. Common Stock (BCAX) ↗BeyondSpring Inc. Ordinary Shares (BYSI) ↗Candel Therapeutics, Inc. Common Stock (CADL) ↗Compugen Ltd (CGEN) ↗Coherus Oncology, Inc. Common Stock (CHRS) ↗Calidi Biotherapeutics, Inc. (CLDI) ↗Coya Therapeutics, Inc. Common Stock (COYA) ↗Corbus Pharmaceuticals Holdings, Inc. (CRBP) ↗Curis Inc (CRIS) ↗CRISPR Therapeutics AG (CRSP) ↗Cue Biopharma, Inc. (CUE) ↗Editas Medicine, Inc. Common Stock (EDIT) ↗Fortress Biotech, Inc. (FBIO) ↗Greenwich LifeSciences, Inc. (GLSI) ↗GeoVax Labs, Inc. New (GOVX) ↗Werewolf Therapeutics, Inc. Common Stock (HOWL) ↗ImmunityBio, Inc. Common Stock (IBRX) ↗Immix Biopharma, Inc. Common Stock (IMMX) ↗Immunic, Inc. Common Stock (IMUX) ↗IN8bio, Inc. Common Stock (INAB) ↗Inhibrx Biosciences, Inc. Common Stock (INBX) ↗Century Therapeutics, Inc. Common Stock (IPSC) ↗Moleculin Biotech, Inc. (MBRX) ↗MeiraGTx Holdings plc Ordinary Shares (MGTX) ↗Monopar Therapeutics Inc. Common Stock (MNPR) ↗Marker Therapeutics, Inc. Common Stock (MRKR) ↗Nektar Therapeutics (NKTR) ↗Intellia Therapeutics, Inc (NTLA) ↗Opko Health Inc. (OPK) ↗Oruka Therapeutics, Inc. Common Stock (ORKA) ↗Phio Pharmaceuticals Corp. Common Stock (PHIO) ↗Pyxis Oncology, Inc. Common Stock (PYXS) ↗SELLAS Life Sciences Group, Inc. Common Stock (SLS) ↗Vir Biotechnology, Inc. Common Stock (VIR) ↗Xenetic Biosciences, Inc. (XBIO) ↗Zenas BioPharma, Inc. Common Stock (ZBIO) ↗Zura Bio Limited Class A Ordinary Shares (ZURA) ↗AETHLON MEDICAL INC (AEMD) ↗Agenus Inc. (AGEN) ↗Ainos, Inc. Common Stock (AIMD) ↗Alzamend Neuro, Inc. Common Stock (ALZN) ↗Anixa Biosciences, Inc. (ANIX) ↗Artiva Biotherapeutics, Inc. Common Stock (ARTV) ↗Atossa Therapeutics, Inc. Common Stock (ATOS) ↗Perspective Therapeutics, Inc. (CATX) ↗Celularity Inc. Class A Common Stock (CELU) ↗Creative Medical Technology Holdings, Inc. Common Stock (CELZ) ↗Context Therapeutics Inc. Common Stock (CNTX) ↗Caribou Biosciences, Inc. Common Stock (CRBU) ↗Cel-Sci Corporation (CVM) ↗Edesa Biotech, Inc. Common Shares (EDSA) ↗Elicio Therapeutics, Inc. Common Stock (ELTX) ↗Enlivex Ltd. Ordinary Shares (ENLV) ↗Equillium, Inc. Common Stock (EQ) ↗Estrella Immunopharma, Inc. Common Stock (ESLA) ↗Fate Therapeutics, Inc. (FATE) ↗Genprex, Inc. Common Stock (GNPX) ↗GRI Bio, Inc. Common Stock (GRI) ↗HCW Biologics Inc. Common Stock (HCWB) ↗TuHURA Biosciences, Inc. Common Stock (HURA) ↗iBio, Inc. Common Stock (IBIO) ↗Insight Molecular Diagnostics Inc. Common Stock (IMDX) ↗Imunon, Inc. Common Stock (IMNN) ↗Indaptus Therapeutics, Inc. Common Stock (INDP) ↗MiNK Therapeutics, Inc. Common Stock (INKT) ↗INmune Bio Inc. Common stock (INMB) ↗Inovio Pharmaceuticals, Inc. (INO) ↗INVO Fertility, Inc. Common Stock (IVF) ↗Kairos Pharma, Ltd. (KAPA) ↗Liminatus Pharma, Inc. Class A Common Stock (LIMN) ↗Lunai Bioworks Inc. Common Stock (LNAI) ↗MAIA Biotechnology, Inc. (MAIA) ↗Neuphoria Therapeutics Inc. Common Stock (NEUP) ↗NextCure, Inc. Common Stock (NXTC) ↗Omeros Corporation (OMER) ↗OS Therapies Incorporated (OSTX) ↗PDS Biotechnology Corporation Common Stock (PDSB) ↗Precigen, Inc. Common Stock (PGEN) ↗Q32 Bio Inc. Common Stock (QTTB) ↗Revelation Biosciences, Inc. Common Stock (REVB) ↗SAB Biotherapeutics, Inc. Common Stock (SABS) ↗Summit Therapeutics Inc. Common Stock (SMMT) ↗Senti Biosciences Holdings, Inc. Common Stock (SNTI) ↗Sutro Biopharma, Inc. (STRO) ↗Alaunos Therapeutics, Inc. Common Stock (TCRT) ↗TriSalus Life Sciences, Inc. Common Stock (TLSI) ↗Theriva Biologics, Inc. (TOVX) ↗Tevogen Inc. Common Stock (TVGN) ↗Vor Biopharma Inc. Common Stock (VOR) ↗XBiotech Inc (XBIT) ↗Xilio Therapeutics, Inc. Common Stock (XLO) ↗
Dates and coverage
Report dates range from 2025-07-28 to 2025-12-31. Market observations range from 2026-10-08 to 2026-10-08. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 47 companies without a report, 0 with invalid latest rating metadata, 1 with older reports, 2 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.